PRISM BioLab Co.,LTD
株式会社ＰＲＩＳＭ ＢｉｏＬａｂ
Valuation
Fundamental ratios for the latest reported period.
Ticker: 206A
FY2024 · 2025-09-30
| Gross margin | 39.8% |
| Operating margin | -114.3% |
| Net margin | -123.1% |
| Return on equity | — |
| Return on assets | -27.0% |
| Revenue growth (YoY) | 121.6% |
| EPS (basic) | ¥-22.82 |
| EPS growth (YoY) | — |
| Current ratio | 8.21x |
| Equity ratio | 87.6% |
| Book value / share | ¥73.4 |
| Free cash flow | -1,533 M |